Stugeron en es it fr

Stugeron Brand names, Stugeron Analogs

Stugeron Brand Names Mixture

  • No information avaliable

Stugeron Chemical_Formula

C26H28N2

Stugeron RX_link

No information avaliable

Stugeron fda sheet

Stugeron msds (material safety sheet)

Stugeron Synthesis Reference

No information avaliable

Stugeron Molecular Weight

368.514 g/mol

Stugeron Melting Point

No information avaliable

Stugeron H2O Solubility

750 mg/L

Stugeron State

Solid

Stugeron LogP

5.63

Stugeron Dosage Forms

No information avaliable

Stugeron Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Stugeron Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Stugeron Absorption

No information avaliable

Stugeron side effects and Toxicity

No information avaliable

Stugeron Patient Information

No information avaliable

Stugeron Organisms Affected

Humans and other mammals